Eric Broyles
Founder at Nanocan Therapeutics Corp.
Profile
Eric Broyles is the founder of Nanocan Therapeutics Corp.
Prior to founding Nanocan Therapeutics Corp, he worked as the Director-Legal, Economic & Regulatory Affairs at Gerson Lehrman Group, Inc. He received his undergraduate degrees from the University of Virginia and the University of Cincinnati (Ohio).
Eric Broyles active positions
Companies | Position | Start |
---|---|---|
Nanocan Therapeutics Corp.
Nanocan Therapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Nanocan Therapeutics Corporation is an early-stage biotechnology company that develops nanotechnology-based innovations to treat cancers where current interventions are insufficient. The company is based in Princeton, NJ. The company aims to create a new standard of care for cancer patients through its partnerships with leading academic research institutions. Nanocan is committed to making its disruptive innovations available to cancer patients in low and middle-income countries. The company was founded by Jacques Walker and Eric Broyles, and Eric Broyles has been the CEO since incorporation. | Founder | - |
Former positions of Eric Broyles
Companies | Position | End |
---|---|---|
Gerson Lehrman Group, Inc.
Gerson Lehrman Group, Inc. Miscellaneous Commercial ServicesCommercial Services Gerson Lehrman Group, Inc. provides membership network for learning and expertise. The firm promotes knowledge exchange through conversations, small group convenings, mentorships, surveys, and other interactions with its network of experts. The company was founded by Alexander Saint-Amand, Thomas D. Lehrman, and Mark Gerson in 1998 and is headquartered in New York, NY. | General Counsel | - |
Training of Eric Broyles
University of Cincinnati (Ohio) | Undergraduate Degree |
University of Virginia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Gerson Lehrman Group, Inc.
Gerson Lehrman Group, Inc. Miscellaneous Commercial ServicesCommercial Services Gerson Lehrman Group, Inc. provides membership network for learning and expertise. The firm promotes knowledge exchange through conversations, small group convenings, mentorships, surveys, and other interactions with its network of experts. The company was founded by Alexander Saint-Amand, Thomas D. Lehrman, and Mark Gerson in 1998 and is headquartered in New York, NY. | Commercial Services |
Nanocan Therapeutics Corp.
Nanocan Therapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Nanocan Therapeutics Corporation is an early-stage biotechnology company that develops nanotechnology-based innovations to treat cancers where current interventions are insufficient. The company is based in Princeton, NJ. The company aims to create a new standard of care for cancer patients through its partnerships with leading academic research institutions. Nanocan is committed to making its disruptive innovations available to cancer patients in low and middle-income countries. The company was founded by Jacques Walker and Eric Broyles, and Eric Broyles has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Eric Broyles